BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osorio C, Kanukuntla T, Diaz E, Jafri N, Cummings M, Sfera A. The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling. Front Aging Neurosci 2019;11:143. [PMID: 31297054 DOI: 10.3389/fnagi.2019.00143] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Clark IA, Vissel B. Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches. J Alzheimers Dis 2021;79:931-48. [PMID: 33459706 DOI: 10.3233/JAD-201186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Welcome MO. Blood brain barrier inflammation and potential therapeutic role of phytochemicals. PharmaNutrition 2020;11:100177. [DOI: 10.1016/j.phanu.2020.100177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
3 Vaiserman A, Koliada A, Lushchak O. Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics. Mech Ageing Dev 2020;189:111259. [PMID: 32450086 DOI: 10.1016/j.mad.2020.111259] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
4 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shabbir U, Arshad MS, Sameen A, Oh DH. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients 2021;13:690. [PMID: 33669988 DOI: 10.3390/nu13020690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
6 Gurven MD, Lieberman DE. WEIRD bodies: mismatch, medicine and missing diversity. Evol Hum Behav 2020;41:330-40. [PMID: 33100820 DOI: 10.1016/j.evolhumbehav.2020.04.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
7 Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease. CNS Drugs 2020;34:673-95. [PMID: 32458360 DOI: 10.1007/s40263-020-00737-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Yamada C, Akkaoui J, Ho A, Duarte C, Deth R, Kawai T, Nichols F, Lakshmana MK, Movila A. Potential Role of Phosphoglycerol Dihydroceramide Produced by Periodontal Pathogen Porphyromonas gingivalis in the Pathogenesis of Alzheimer's Disease. Front Immunol 2020;11:591571. [PMID: 33329577 DOI: 10.3389/fimmu.2020.591571] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Olsen I. Porphyromonas Gingivalis May Seek the Alzheimer's Disease Brain to Acquire Iron from Its Surplus. J Alzheimers Dis Rep 2021;5:79-86. [PMID: 33681719 DOI: 10.3233/ADR-200272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ryder MI, Xenoudi P. Alzheimer disease and the periodontal patient: New insights, connections, and therapies. Periodontol 2000 2021;87:32-42. [PMID: 34463981 DOI: 10.1111/prd.12389] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Guidolin D, Anderlini D, Marcoli M, Cortelli P, Calandra-Buonaura G, Woods AS, Agnati LF. A New Integrative Theory of Brain-Body-Ecosystem Medicine: From the Hippocratic Holistic View of Medicine to Our Modern Society. Int J Environ Res Public Health 2019;16:E3136. [PMID: 31466374 DOI: 10.3390/ijerph16173136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Sanders O. Sildenafil for the Treatment of Alzheimer's Disease: A Systematic Review. J Alzheimers Dis Rep 2020;4:91-106. [PMID: 32467879 DOI: 10.3233/ADR-200166] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
13 De la Fuente M. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease. J Alzheimers Dis 2021;81:1345-60. [PMID: 33935086 DOI: 10.3233/JAD-201587] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gomaa AA, Farghaly HA, Abdel-Wadood YA, Gomaa GA. Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2167-85. [PMID: 34542667 DOI: 10.1007/s00210-021-02154-7] [Reference Citation Analysis]
15 Jamerlan A, An SSA, Hulme J. Advances in amyloid beta oligomer detection applications in Alzheimer's disease. TrAC Trends in Analytical Chemistry 2020;129:115919. [DOI: 10.1016/j.trac.2020.115919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
16 D'Arrigo JS. Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades. Biomimetics (Basel) 2020;5:E11. [PMID: 32244941 DOI: 10.3390/biomimetics5010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Moreno-Arribas MV, Bartolomé B, Peñalvo JL, Pérez-Matute P, Motilva MJ. Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer's Disease. Nutrients 2020;12:E3082. [PMID: 33050383 DOI: 10.3390/nu12103082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
18 Pastore A, Raimondi F, Rajendran L, Temussi PA. Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides? Commun Biol 2020;3:135. [PMID: 32193491 DOI: 10.1038/s42003-020-0865-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
19 D'Arrigo JS. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia. Am J Alzheimers Dis Other Demen 2020;35:1533317520976761. [PMID: 33307726 DOI: 10.1177/1533317520976761] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kramer P, Bressan P. Infection threat shapes our social instincts. Behav Ecol Sociobiol 2021;75:47. [PMID: 33583997 DOI: 10.1007/s00265-021-02975-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Neuropsychiatr Dis Treat 2021;17:1311-39. [PMID: 33976546 DOI: 10.2147/NDT.S264910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Altiné‐samey R, Antier D, Mavel S, Dufour‐rainfray D, Balageas A, Beaufils E, Emond P, Foucault‐fruchard L, Chalon S. The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease. Fundam Clin Pharmacol 2021;35:582-94. [DOI: 10.1111/fcp.12654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Beg AZ, Khan AU. Motifs and interface amino acid-mediated regulation of amyloid biogenesis in microbes to humans: potential targets for intervention. Biophys Rev 2020;12:1249-56. [PMID: 32930961 DOI: 10.1007/s12551-020-00759-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Quan H, Koltai E, Suzuki K, Aguiar AS Jr, Pinho R, Boldogh I, Berkes I, Radak Z. Exercise, redox system and neurodegenerative diseases. Biochim Biophys Acta Mol Basis Dis 2020;1866:165778. [PMID: 32222542 DOI: 10.1016/j.bbadis.2020.165778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Ungerleider K, Beck J, Lissa D, Turnquist C, Horikawa I, Harris BT, Harris CC. Astrocyte senescence and SASP in neurodegeneration: tau joins the loop. Cell Cycle 2021;20:752-64. [PMID: 33818291 DOI: 10.1080/15384101.2021.1909260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]